Administration af voriconazol medførte et mindre fald i steady- state Cmax og AUC for ritonavir (90% KI) med i gennemsnit henholdsvis 24% (↓6% til ↓39%) og 14% (↓26% til ↑1%).
Administration of voriconazole resulted in a minor decrease in steady state Cmax and AUC of ritonavir (90% CI) with an average of 24% (↓ 6% to ↓ 39%) and 14% (↓ 26% to ↑ 1%), respectively.